Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06583902
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-02
Brief Title:
Management of Anemia in Patients with EndocaRditis Infectious Candidates for Cardiac Surgery the AMERICA Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Management of Anaemia in Patients with Infectious Endocarditis Who Are Candidates for Cardiac Surgery the AMERICA Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AMERICA
Brief Summary:
Infective endocarditis EI is an extremely serious disease requiring prolonged hospitalisation complex management by multidisciplinary teams and high healthcare costs Anemia is also emerging as a virtually constant condition associated with endocarditis as evidenced by its inclusion in the variables used to calculate risk scoresAnemia associated with infective endocarditis EI has a remarkably complex and multifactorial pathogenesisIt is essential to treat anaemia in patients with EI as an integral part of their overall therapy in what is now called patient blood management Blood transfusion is not the only approach available to treat this condition It is essential to correct any deficiencies whether iron or vitamins In addition some patients may benefit from the administration of erythropoiesis-stimulating agents
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None